Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1 participants
OBSERVATIONAL
2017-09-09
2018-02-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dose Response Study of Transdermal Human Insulin in Patients
NCT05159453
Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes
NCT00922649
Transdermal Basal Insulin Patch Study in Type 1 Diabetes
NCT00519623
Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes
NCT07325461
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus
NCT03849612
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A series of formulations were produced at varing dose strengths and in conjunction with injected insulin products, applied and serum glucose measured to ascertain response and optimize a fomrula to be submitted for IND approval.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TD Insulin Pilot
Test of novel transdermal insulin (TD Insulin) formulations
TD Insulin
Human Insulin USP formulated in a solution capable of transdermal delivery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TD Insulin
Human Insulin USP formulated in a solution capable of transdermal delivery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* well managed serum glucose
60 Years
61 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Transdermal Delivery Solutions Corp
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William D Kirsh, D.O.
Role: PRINCIPAL_INVESTIGATOR
Sentry Data Systems
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Langford Research Institute
Palm Beach Gardens, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TDS INS-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.